📊 Score Breakdown
Offering Ability
60
Cash Runway
85
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
45%
📉 Score Deterioration
50%
• Score rose 42 points recently (worsening)
• Score in HIGH risk zone (66/100)
🔄 Reverse Split
45%
• 50-day avg $1.36 approaching $1 threshold
• Only 6 months cash — financial pressure
💰 Capital Raise
35%
• Low cash runway: 6 months remaining
💹 Market Data
Market Cap$290.62M
Shares Outstanding218.51M
FloatN/A
Cash$6.20M
Debt$5.80M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest25.2K
Days to Cover9.9
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for RNLXY
📊 RNLXY FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RNLXY Signal Convergence & Dark Pool Activity — StonkWhisper
📄 RNLXY Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.